Skip to content
Screener

Price / book at other companies

Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
2.6×+0.8×
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
4.7×+0.8×
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
4.9×+3.8×
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
4.7×+3.0×
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
3.9×-0.5×
Biogen logo
BiogenBIIB
1.7×+0.6×

Other financials

Income statement

See full
Revenue--100%
Operating income-$96.9M-27.4%
Net income-$83.7M-17.7%
EPS (diluted)-$2.87+13.3%

Balance sheet

See full
Cash & equivalents$474.8M+201%
Total debt$1.1M+44.0%
Total equity$1.3B+232%
Total assets$1.4B+207%

Cash flow

See full
Operating cash flow-$77.5M-41.8%
CapEx$245.0K+338%
Free cash flow-$77.8M-42.1%

Valuation

See full
Market cap$8.9B+770%
Enterprise value$8.43B+873%

Profitability

See full
Operating margin-3,927.5%-1,497pp
Net margin-3,658.5%-1,388pp
FCF margin-3,067.4%-1,030pp

Returns & leverage

See full
Return on equity-38.9%-10.3pp
Debt / equity0.0×
Current ratio15.7×+9.4×

Where this comes from

Calculated from Praxis Precision Medicines, Inc.’s reported figures.

Based on the most recent quarter.

The source filing: Praxis Precision Medicines, Inc.’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 8:32 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001689548-26-000083

FAQ

What is Praxis Precision Medicines, Inc.'s price / book?
Praxis Precision Medicines, Inc. (PRAX) reported price / book of 7× in Q2 2026.
How has Praxis Precision Medicines, Inc.'s price / book changed year-over-year?
Praxis Precision Medicines, Inc.'s price / book increased by 214.2% year-over-year, from 2.2× to 7×.
What is the long-term trend for Praxis Precision Medicines, Inc.'s price / book?
Over 5 years (2020 to 2025), Praxis Precision Medicines, Inc.'s price / book has grown at a -0.5% compound annual growth rate (CAGR), from 8.6× to 8.4×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

Ask your AI about Praxis Precision Medicines, Inc.'s price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude